These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17710308)

  • 1. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
    Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
    Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Potential CD4
    E Silva RF; de Oliveira BC; da Silva AA; Brelaz de Castro MCA; Ferreira LFGR; Hernandes MZ; de Brito MEF; de-Melo-Neto OP; Rezende AM; Pereira VRA
    Front Immunol; 2019; 10():3145. PubMed ID: 32117204
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.
    Da-Cruz AM; Oliveira-Neto MP; Bertho AL; Mendes-Aguiar CO; Coutinho SG
    J Invest Dermatol; 2010 May; 130(5):1329-36. PubMed ID: 20107484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F1F3 Recombinant Chimera of
    Alves-Silva MV; Nico D; de Luca PM; Palatnik de-Sousa CB
    Front Immunol; 2019; 10():724. PubMed ID: 31024556
    [No Abstract]   [Full Text] [Related]  

  • 9. Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
    Ferraz R; Cunha CF; Gomes-Silva A; Schubach AO; Pimentel MI; Lyra MR; Mendonça SC; Valete-Rosalino CM; Da-Cruz AM; Bertho ÁL
    BMC Infect Dis; 2015 Feb; 15():74. PubMed ID: 25870976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.
    Pereira-Carvalho R; Mendes-Aguiar CO; Oliveira-Neto MP; Covas CJ; Bertho AL; Da-Cruz AM; Gomes-Silva A
    PLoS One; 2013; 8(11):e81529. PubMed ID: 24303052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and Functional Profiles of Antigen-Specific CD4
    Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
    Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.
    Da-Cruz AM; Bittar R; Mattos M; Oliveira-Neto MP; Nogueira R; Pinho-Ribeiro V; Azeredo-Coutinho RB; Coutinho SG
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):251-6. PubMed ID: 11874860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.
    Mendes-Aguiar Cde O; Gomes-Silva A; Nunes E; Pereira-Carvalho R; Nogueira RS; Oliveira-Neto Mde P; Bertho AL; Da-Cruz AM
    Clin Exp Immunol; 2009 Sep; 157(3):377-84. PubMed ID: 19664146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.
    Keesen TS; Antonelli LR; Faria DR; Guimarães LH; Bacellar O; Carvalho EM; Dutra WO; Gollob KJ
    Clin Exp Immunol; 2011 Sep; 165(3):338-51. PubMed ID: 21726211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation.
    Antonelli LR; Dutra WO; Almeida RP; Bacellar O; Gollob KJ
    Clin Exp Immunol; 2004 May; 136(2):341-8. PubMed ID: 15086400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.
    Sassi A; Louzir H; Ben Salah A; Mokni M; Ben Osman A; Dellagi K
    Clin Exp Immunol; 1999 Apr; 116(1):127-32. PubMed ID: 10209516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
    Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
    Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
    Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.